Healthcare -
Biotechnology - NASDAQ - US
$ 18.37
-0.541 %
$ 1.6 B
Market Cap
-4.06
P/E
TVTX - ACCOUNTS PAYABLE
Accounts Payable TVTX - Travere Therapeutics, Inc.
41.7 M
LAST VALUE
65.89%
2 YEAR CAGR
43.06%
5 YEAR CAGR
27.91%
10 YEAR CAGR